The American public cannot stand by as pharmaceutical companies bring unsafe drugs to market in the name of profit.
St. Louis, Missouri (PRWEB) May 22, 2010
A report due this summer from the U.S. Food & Drug Administration reaffirms the dangers of heart attack and heart failure that the diabetes drug Avandia poses to patients, a Missouri legal firm that assists victims of personal injury says.
The FDA in August 2009 received data from a large, long-term clinical study on possible risks with Avandia (rosiglitazone), which is prescribed to treat type 2 diabetes. In an FDA Drug Safety Communication published February 22, 2010, the federal regulator said it will present a summary of the study at the upcoming Advisory Committee meeting in July 2010.
However, The New York Times said in February that the study goes so far as to recommend that the government ban sales of Avandia, which is manufactured by GlaxoSmithKline Plc. The newspaper named two of the study’s authors, Dr. David Graham and Dr. Kate Gelperin, and said both recommend Avandia's withdrawal from the market.
Avandia has been primarily linked to congestive heart failure and heart attack, but also to liver toxicity, severe allergic reaction and stroke. In the third quarter of 2009, 304 deaths were blamed on the use of Avandia, according to a report from the Institute for Safe Medication Practice.
“It has been clear for years that Avandia is a harmful drug,” said Jeff Singer, a personal injury attorney with Fox, Singer & Goldblatt, P.C. of St. Louis. “We contend that GlaxoSmithKline either knew or should have known about this problem for several years.”
In May 2007, an FDA alert said there was “a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia.” The agency asked GlaxoSmithKline to conduct further studies to examine cardiovascular risks.
The FDA in November 2007 ordered stricter warnings about the potential increased risk for heart attacks in patients taking Avandia.
“The American public cannot stand by as pharmaceutical companies bring unsafe drugs to market in the name of profit,” Singer said. “We at Fox, Goldblatt & Singer will stand up for those who have been harmed, and we'll work to obtain justice on their behalf.”
About Fox, Goldblatt & Singer, P.C.
Established in 1949, the St. Louis, Missouri, personal injury law firm of Fox, Goldblatt & Singer, P.C. has extensive experience with defective drug cases, as well as car accidents, truck accidents, motorcycle accidents, workers’ compensation law, premises liability and medical malpractice. Call the firm's lawyers today at (877) 858-4699 or contact them at http://www.stlinjurylaw.com to discuss your case. The firm serves injury victims throughout the United States, as well as those injured in the communities of St. Louis, Florissant, Chesterfield, University City, Clayton, O’Fallon, St. Charles, St. Peters, St. Louis County and St. Charles County, MO, and throughout Alton, Belleville, Madison County and St. Claire County, IL.
# # #